Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2025-04-17 Remuneration Information
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
关于对公司董事、监事、高级管理人员2024年度薪酬予以确认及2025年度薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the confirmation of the 2024 annual remuneration and the 2025 remuneration plan for the company's directors, supervisors, and senior management. It includes detailed salary figures and the approval process by the board and supervisory committee. The content focuses on remuneration information for top executives and directors, which aligns with the definition of Remuneration Information filings. The document is not a full annual report or financial statement but a specific announcement about executive compensation plans and confirmations.
2025-04-17 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告' which translates to 'Annual Report' and covers the fiscal year 2024. It includes detailed sections such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management details, industry information, corporate governance, and full financial accounting reports. The document contains comprehensive financial data, management analysis, and audited financial statements with an unqualified audit opinion. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial tables, management discussion, and audit confirmation aligns with the characteristics of an official yearly report covering company activity and full financial performance. Therefore, this document is classified as an Annual Report (10-K). FY 2024
2025-04-17 Chinese
第四届监事会第七次会议决议
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the seventh meeting of the fourth Supervisory Board of Wuxi Jinghai Amino Acid Co., Ltd. It includes multiple agenda items such as approval of the 2024 audit report, 2024 annual report and its summary, 2024 Supervisory Board work report, 2024 financial statements, 2025 financial budget, related party transactions, dividend distribution plan, use of idle funds, non-operating fund occupation report, internal control self-assessment report, internal control audit report, and confirmation of Supervisory Board remuneration. The document repeatedly states that the detailed reports are disclosed separately on the Beijing Stock Exchange information disclosure platform and that these resolutions are to be submitted to the shareholders' meeting for approval where applicable. The document itself is a meeting resolution announcement rather than the reports themselves. It is a formal disclosure of the Supervisory Board meeting decisions, which fits the category of Board/Management Information (MANG). The document length is about 4695 characters, which is not extremely short, but the content is clearly about meeting resolutions and approvals, not the reports themselves. Therefore, the best classification is MANG with high confidence.
2025-04-17 Chinese
无锡晶海氨基酸股份有限公司董事会关于独立董事独立性情况的专项意见
Governance Information Classification · 95% confidence The document is a special opinion from the board regarding the independence of the company's independent directors. It references compliance with the China Securities Regulatory Commission's rules on independent directors and provides detailed assessments of the directors' independence. There is no financial data, no mention of annual or interim reports, no voting results, no management changes, and no earnings information. The content is focused on governance and compliance related to board members' independence. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-04-17 Chinese
关于预计公司2025年度日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected related party transactions for the year 2025 by Wuxi Jinghai Amino Acid Co., Ltd. It includes details about the nature of the transactions, the related party involved, the expected transaction amounts, the decision-making and approval process by the board and supervisory committee, pricing policies, and the impact on the company. It also contains opinions from the sponsoring institution and references to meeting resolutions. The document is a regulatory announcement about anticipated related party transactions rather than a financial report or detailed management analysis. It does not contain financial statements or detailed financial data but is a formal disclosure of expected transactions and approvals. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-17 Chinese
东方证券股份有限公司关于无锡晶海氨基酸股份有限公司2024年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from 东方证券股份有限公司 (Orient Securities Co., Ltd.) regarding the 2024 annual special audit opinion on the deposit and use of raised funds by 无锡晶海氨基酸股份有限公司 (Wuxi Jinghai Amino Acid Co., Ltd.). It includes specifics about the amount of funds raised, usage, balance, cash management, and compliance with regulatory requirements. The document references regulatory rules from the Beijing Stock Exchange and includes audit opinions and verification reports from an accounting firm. The content is focused on the management and use of capital raised through public stock issuance, with detailed financial figures and compliance statements. This matches the definition of an Audit Report / Information (AR), which covers standalone audit reports and applied accounting principles related to specific financial activities, excluding full annual reports. The document is 8030 characters long, which is substantial and contains detailed financial data and audit opinions, not merely an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-17 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.